Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2007
03/21/2007EP1763334A2 Keratin-binding polypeptides
03/21/2007EP1696945A4 Self-assembling peptide amphiphiles and related methods for growth factor delivery
03/21/2007EP1689882A4 Radioactive multiplexing analytical methods
03/21/2007EP1576171A4 Amino acid transporters
03/21/2007EP1397492B1 Modified and stabilized gdf propeptides and uses thereof
03/21/2007EP1383534B1 Chalamydia vaccine based on blebs
03/21/2007EP1341899B9 Bacterial host strains
03/21/2007EP1339735B1 Method for preparing tryptophan rich peptides
03/21/2007EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf
03/21/2007EP1334195B1 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases
03/21/2007EP1331228B1 Method of screening antiplatelet
03/21/2007EP1320608B1 Nucleotide sequences which code for the msik gene
03/21/2007EP1313856B1 Citb gene from corynebacteria and use thereof in snythesis of l-amino acids
03/21/2007EP1311685B1 Nucleotide sequences which code for the ccpa1 gene
03/21/2007EP1292327B1 IMMUNIZATION OF DAIRY CATTLE WITH Mig PROTEIN
03/21/2007EP1280397B1 Transcription factor stress-related proteins and methods of use in plants
03/21/2007EP1235918B1 Methods for altering the expression of hyphal-specific genes
03/21/2007EP1222263B1 ISOLATION AND CHARACTERIZATION OF A FIBER-SPECIFIC ß-TUBULIN PROMOTER FROM COTTON
03/21/2007EP1216259B1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium
03/21/2007EP1115425B1 Autoantibody inhibitors
03/21/2007EP1105496B1 Modified hcv peptide vaccines
03/21/2007EP1007088B1 Recombinant porcine adenovirus vector
03/21/2007EP0950107B1 Novel nucleic acid molecules from maize and their use for the production of modified starch
03/21/2007EP0907724B1 Von willebrand factor multimerase
03/21/2007EP0865446B1 Agents for promoting bone formation
03/21/2007CN1934720A Semiconductor light-emitting device and illuminating device
03/21/2007CN1934265A Process for the production of l-amino acids using coryneform bacteria
03/21/2007CN1934259A Plants having improved growth characteristics and method for making the same
03/21/2007CN1934248A HBV variants detection and application
03/21/2007CN1934245A Method of proliferating pluripotent stem cell
03/21/2007CN1934242A Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
03/21/2007CN1934240A Attenuated gram negative bacteria
03/21/2007CN1934132A Cyanide tolerant nitrilhydratases
03/21/2007CN1934131A Optimized expression of hpv 52 l1 in yeast
03/21/2007CN1934129A Fractionator and method of fractionation
03/21/2007CN1934128A Process for producing human serum albumin by heating in presence of divalent cation
03/21/2007CN1934123A Intracellular delivery of osteoinductive proteins and peptides
03/21/2007CN1933848A Y2 selective receptor agonists for therapeutic interventions
03/21/2007CN1932017A Tumor adoptosis inducing ligandin and its application in preparing antitumor medicine
03/21/2007CN1932016A Polynucleotide affecting SRE activity and its coding polypeptides and use
03/21/2007CN1932012A ARCELIN-5 promoter and uses thereof
03/21/2007CN1931875A High purity ulinastatin and its prepn process and medicine composition
03/21/2007CN1931874A Prepn process, medicine prepn and medicinal use of ginseng glycopeptide
03/21/2007CN1931365A Hcv e1e2 vaccine compositions
03/21/2007CN1931359A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931358A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1306036C Method for preparing interferon of white blood cells of dogs
03/21/2007CN1306033C Production of vaccines
03/21/2007CN1306031C Novel natural antibacterial peptide Hippocampusin and its preparation and application
03/21/2007CN1305931C Agent for the prevention and treatment of sexually transmitted diseases-1
03/21/2007CN1305906C Use of antibodies against specific MHC-Peptide complexes
03/21/2007CN1305903C Method for retrieving albumin from deposited components I, II, III, IV
03/21/2007CN1305902C Method for preparing human interleukin 29 and recombinant IL-29 engineering strain
03/21/2007CN1305901C Tumor transfer related protein and coding gene thereof
03/21/2007CN1305900C Use of Esat-6 protein in diagnosis of tuberculosis
03/21/2007CN1305899C Therapeutic peptides
03/21/2007CN1305898C Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus
03/21/2007CN1305897C New peptide compounds, process for their preparation and pharmaceutical compositions containing them
03/21/2007CN1305374C Protein for promoting plant growth and enhancing disease resistance of plant, and synthetic gene
03/20/2007US7193143 Plants and seeds of corn variety LH332
03/20/2007US7193134 Genetic engineered plants
03/20/2007US7193133 Plastid transit peptides
03/20/2007US7193132 Construction of a chimeric gene encoding all or a portion of the (myeloblastosis) Myb-related transcription factor to improve crop plants for a variety of traits, including disease and pest resistance, and grain quality improvements
03/20/2007US7193129 Stress-related polynucleotides and polypeptides in plants
03/20/2007US7193125 Trangenic rodent for use as model in evaluation of xenobiotics
03/20/2007US7193075 Sequences upstream of the CARP gene, vectors containing them and uses thereof
03/20/2007US7193072 Nucleotide sequence coding preferential polypeptide for use in the treatment and prevention of bacterial infections in swine
03/20/2007US7193070 Isolated DNA molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
03/20/2007US7193069 Comprise polynucleotide for treating cancer and inflammatory disorders; antisense therapy; gene therapy
03/20/2007US7193066 Proteolytically treated holotoxin of clostridial neurotoxin is purified by immunoaffinity chromatography or matched ion polynucleotide chromatography
03/20/2007US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors
03/20/2007US7193063 Antibodies to a polypeptide encoded by a nucleic acid overexpressed in esophageal tumor, normal stomach and melanoma
03/20/2007US7193058 Monoclonal antibody which recognizes membrane glycoprotein (ULBP) for use in treatment and prevention of cell proliferative disorders; immunotherapy
03/20/2007US7193056 Process for purifying a compound
03/20/2007US7193055 Compaction assay for assessment of respiratory disease therapy
03/20/2007US7193054 Masking of two-dimentsional surfaces and non-conductive three dimensional spacers; high-quality one-dimensional nanowires over large areas; nontraditional microlithography methods; pollution control
03/20/2007US7193053 Hypoxia-inducible factor 1alpha variants and methods of use
03/20/2007US7193051 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis
03/20/2007US7193050 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2007US7193049 PRO862 polypeptides
03/20/2007US7193048 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2007US7193047 Identification and isolation of novel DNA and recombinant production of novel polypeptides
03/20/2007US7193046 Polypeptide encoded by a nucleic acid overexpressed in esophageal and lung tumor, and underexpressesd in kidney tumor and melanoma
03/20/2007US7193045 Nucleotide sequences coding polypeptide for use in diagnostics biosensors and thrombolytic agents
03/20/2007US7193044 Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
03/20/2007US7193040 Apoptosis of rectum and prostate cancer
03/20/2007US7193039 Comprises tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid; solid phase synthesis; for immunoassay; electron spin resonance/fluorescence; improved enzyme resistance
03/20/2007US7193038 Nontoxic, stable polypeptide used as cellular adhesion molecules, wound healing agents, cosmetics,and cell culture substrates
03/20/2007US7193035 Asparagine in position B3 and lysine in position B29 are replaced by lysine and glutamic acid, respectively; inhalant and oral dosage forms; dissolving and purifying the amorphous powder; antidiabetic agents
03/20/2007US7193034 Synthetic peptides, conjugation reagents and methods
03/20/2007US7193033 Peptide having appetite stimulating activity
03/20/2007US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
03/20/2007US7192928 T cell antigen receptor peptides
03/20/2007US7192927 An isolated BAX gene frameshift-mutation polypeptide is used to stimulate the proliferation of human T cells, T cellular immunity; for treating cancer patient; cancer vaccines
03/20/2007US7192926 Synthetic blood has a high-molecular weight proteins, containing a low hydroxyproline content for preventing from gelling; prevent anaphylactic shock; genetic engineering; replacement of glutamine by glutamic acid and/or replacement of asparagine by aspartic acid
03/20/2007US7192925 Genetic engineered venoms is a polypeptide, free of cysteine residues and internal disulfide bridges; enzyme resistance to proteinases; treatment of hypertension
03/20/2007US7192924 Corticotropin releasing factor 2 receptor agonists
03/20/2007US7192923 For therapy and prophylaxis of muscular dystrophy
03/20/2007US7192921 Peptides that home to tumor lymphatic vasculature and methods of using same
03/20/2007US7192916 Gene encoding MNR2 and uses thereof